ibrutinib,acalabrutinib
Janssen,Abbvie,astrazeneca
['acalabrutinib', ' ibru', 'bruin', 'cll', 'ascertain']
congress | #ash22 | poster
bhavini srivastava discussed early adherence to 1st line ibrutinib or acalabrutinib in pts with #cll or #sll. general adherence was similar across cohorts. higher adherence at 3mo was observed in pts with atrial fibrillation treated with ibr vs aca. 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm